|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | |||||
| Deferred policy acquisition costs | |||||
| Amortization of policy acquisition costs | |||||
| Net realized and unrealized losses (gains) on investments | |||||
| Net realized and unrealized losses on investments | |||||
| Impairment of intangible assets | |||||
| Distributions from equity method investments | |||||
| Income from equity method investments | |||||
| Loss on disposal of discontinued operations | |||||
| Deferred U.S. federal income tax benefit | |||||
| Provision for depreciation and amortization | |||||
| Share based compensation expense | |||||
| Excess tax benefits from equity incentive plan transactions | |||||
| Change in operating assets and liabilities: | |||||
| Reserve for losses and loss adjustment expenses | |||||
| Unearned premiums | |||||
| Premiums receivable and agents’ balances | |||||
| Reinsurance balances | |||||
| Funds held | |||||
| Payable to insurance companies | |||||
| Other | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing activities | |||||
| Sale of JRG Re | |||||
| Fixed maturity securities: | |||||
| Purchases | |||||
| Sales | |||||
| Maturities and calls | |||||
| Equity Securities: | |||||
| Purchases | |||||
| Sales and redemptions | |||||
| Bank loan participations: | |||||
| Purchases | |||||
| Sales | |||||
| Maturities | |||||
| Other invested assets: | |||||
| Purchases | |||||
| Return of capital | |||||
| Proceeds from sales and repayments | |||||
| Securities receivable or payable, net | |||||
| Short-term investments, net | |||||
| Purchases of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities | |||||
| Senior debt issuances | |||||
| Senior debt repayments | |||||
| Issuance of Series A preferred shares (Note 12) | |||||
| Enstar common stock investment (Note 13) | |||||
| Issuances of common shares under equity incentive plans | |||||
| Payroll taxes withheld and remitted on net settlement of RSUs | |||||
| Dividends on Series A preferred shares | |||||
| Dividends on common stock | |||||
| Payment of debt issuance costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Change in cash, cash equivalents, and restricted cash equivalents | |||||
| Cash, cash equivalents, and restricted cash equivalents at beginning of year | |||||
| Cash, cash equivalents, and restricted cash equivalents at end of year | |||||
| Supplemental information | |||||
| U.S. federal income taxes (refunded) paid, net | |||||
| U.S. state income taxes paid | |||||
| Interest paid | |||||
| Restricted cash equivalents at beginning of year | |||||
| Restricted cash equivalents at end of year | |||||
| Change in restricted cash equivalents | |||||
Loading...